1Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin Ⅱ-mediated cardiovascular and renal diseases [J]. Pharmacol Rev, 2000; 52(1):11-33.
2Chiu AT, Herblin WF, McCall DE, et al. Identification of angiotensin Ⅱ receptor subtypes[J]. Biochem Biophys Res Commun, 1989; 165(1): 196-203.
3Miyata N, Park F, Li XF, et al. Distribution of angiotensin Ⅱ AT1 and AT2 receptor subtypes in the rat kidney [J]. Am J Physiol, 1999; 277(3Pt2): F437-F446.
4Rakugi H, Okamura A, Kamide K, et al. Recognition of tissue- and subtype-specific modulation of angiotensin Ⅱ receptors using antibodies against AT1 and AT2 receptors [J]. Hypertens Res, 1997; 20(1): 51-55.
5Goto M, Mukoyama M, Suga S, et al. Growth-dependent induction of angiotensin Ⅱ type 2 receptor in rat mesangial cells [J]. Hypertension, 1997;30(3Pt1): 358-362.
6Maric C, Aldred GP, Harris PJ, et al. Agiotensin Ⅱ inhibits growth of cultured embryonic renomedullary interstitial cells through the AT2 receptor [J]. Kidney Int, 1998; 53(1): 92-99.
7Siragy HM. AT(1) and AT(2) receptors in the kidney: Role in disease and treatment [J]. Am J Kidney Dis, 2000;36(3 Suppl 1): s4-s9.
